Cw. Miller et al., INTEGRITY OF THE 1,25-DIHYDROXYVITAMIN D-3 RECEPTOR IN BONE, LUNG, AND OTHER CANCERS, Molecular carcinogenesis, 19(4), 1997, pp. 254-257
Differentiation and proliferation can be regulated in diverse cell typ
es by 1,25-dihydroxyvitamin D-3 These effects derive from modulation o
f gene expression mediated by the interaction of 1,25-dihydroxyvitamin
D, with the vitamin D receptor (VDR). The VDR is one of the nuclear h
ormone receptors. Because these transcription factors play a key role
in growth control, some nuclear hormone receptors, such as the retinoi
c acid receptor a, can be disrupted in cancer. With these alterations
in mind, we looked for alterations of the VDR gene in a variety of can
cers, including 68 osteosarcomas, 23 other sarcomas, 34 non-small cell
lung cancers, and 44 cell lines representing many tumor types. Cross
integrity of the VDR gene was examined on Southern blots probed with t
he coding region of the VDR cDNA. The presence of point mutations targ
eting VDR exons 2-7 was assessed by polymerase chain reaction-single-s
trand conformation polymorphism analysis and direct DNA sequencing. Tw
o alterations were detected; direct DNA sequencing of these samples re
vealed one silent mutation in codon 79 and a base change in intron 3.
These results suggest that mutations and rearrangement of the VDR do n
ot play a role in the cancers studied. (C) 1997 Wiley-Liss, Inc.